Search Prime Grants

U54CA254571

Cooperative Agreement

Overview

Grant Description
United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for career development and the prevention, early detection and efficient linkage to care for virus-related cancers.
Awardee
San Francisco Regents Of The University Of California
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.397 - Cancer Centers Support Grants
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
San Francisco, California 94143 United States
Geographic Scope
Single Zip Code
Related Opportunity
U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional) (RFA-CA-20-001)
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/25 to 06/30/26 and the total obligations have increased 436% from $1,054,123 to $5,647,079.
San Francisco Regents Of The University Of California was awarded USEAHAMRC: Career Development & Virus-Related Cancer Care Cooperative Agreement U54CA254571 worth $5,647,079 from National Cancer Institute in July 2020 with work to be completed primarily in San Francisco California United States. The grant has a duration of 6 years and was awarded through assistance program 93.397 Cancer Centers Support Grants. The Cooperative Agreement was awarded through grant opportunity U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
7/13/20
Start Date
6/30/26
End Date
96.0% Complete

Funding Split
$5.6M
Federal Obligation
$0.0
Non-Federal Obligation
$5.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA254571

Subgrant Awards

Disclosed subgrants for U54CA254571

Transaction History

Modifications to U54CA254571

Additional Detail

Award ID FAIN
U54CA254571
SAI Number
U54CA254571-3319656280
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
KMH5K9V7S518
Awardee CAGE
4B560
Performance District
CA-11
Senators
Dianne Feinstein
Alejandro Padilla

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $2,527,010 98%
Modified: 9/24/25